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Abstract 25 
Prospective cohort studies showed inverse associations between fibre intake and 26 
cardiovascular diseases, possibly mediated by blood pressure (BP). However little is known 27 
about the impact of types of fibre on BP. We examined cross-sectional associations to BP of 28 
total, insoluble and soluble fibre intakes. Data were used from the INTERnational study on 29 
MAcro/micronutrients and blood Pressure (INTERMAP) study including 2,195 men and 30 
women ages 40–59 y from the United States. During 4 visits, eight BP, four 24-hour dietary 31 
recalls and two 24-hour urine samples were collected. Linear regression models adjusted for 32 
lifestyle and dietary confounders to estimate BP differences per 2SD higher intakes of total 33 
and individual types of fibre were calculated. After multivariable adjustment, total fibre 34 
intake higher by 6.8 g/1000 kcal was associated with a 1.69 mm Hg lower systolic BP (SBP; 35 
95% CI: -2.97, -0.41) and attenuated to -1.01 mm Hg (95% CI: -2.35, 0.34) after adjustment 36 
for urinary potassium. Insoluble fibre intake higher by 4.6 g/1000 kcal was associated with a 37 
1.81 mm Hg lower SBP (95% CI: -3.65, 0.04), additionally adjusted for soluble fibre and 38 
urinary potassium excretion, while soluble fibre was not associated with BP. Raw fruit was 39 
the main source of total and insoluble fibre, followed by whole grains and vegetables. In 40 
conclusion, higher intakes of fibre, especially insoluble, may contribute to lower BP. This 41 
may be explained by related potassium intake present in high-fibre foods. 42 
Abstract word count: 233 43 
Text word count: 3,193  44 
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Introduction 45 
High blood pressure (BP) is a major independent risk factor for cardiovascular diseases 46 
(CVD) (1).  Meta-analyses of prospective cohort studies showed that higher intake of total 47 
dietary fibre is associated with a lower risk of fatal and non-fatal coronary events (2, 3). 48 
Reported cross-sectional findings of total fibre intake and BP, however, were inconsistent: 49 
some show inverse associations (4-6), while others observed no association (7, 8). The 50 
limited available prospective cohort studies found inverse relations between total fibre intake 51 
and BP rise (9), or risk of hypertension (4, 5). Methodological limitations in these studies 52 
include validity of dietary assessment methods (4-6, 8), absent or limited adjustment for 53 
dietary and other lifestyle confounders (6, 8, 10), substitution of fibre supplements rather than 54 
dietary fibre sources (11,12), and inadequate frequency of BP measurement (6-8). Meta-55 
analyses of randomized controlled intervention studies showed that fibre supplementation 56 
(average dose, 11.5 g/d) did not significantly reduce BP (11, 12), but significant BP-lowering 57 
effects were found in hypertensive participants (12). It has been suggested that the 58 
mechanism by which higher dietary fibre intakes may lower BP is attributed to enhanced 59 
insulin sensitivity that may improve endothelial function and other CVD risk factors (11). 60 
The potential effect of insoluble fibre on BP has been less thoroughly investigated. Soluble 61 
fibre may have a favourable effect on BP by lowering postprandial glucose responses and 62 
LDL cholesterol levels, stimulating the absorption of minerals in the gastrointestinal system, 63 
and reducing body weight (11, 12). Inconsistent findings on the effect of dietary fibre on BP 64 
may relate to differences in study design (13-17): BP responses to fibre intake may depend on 65 
type (insoluble or soluble) or dose of fibre, and whether supplemental fibre or high-fibre 66 
dietary sources were consumed (e.g., whole-grain bread) (11). To our knowledge, only one 67 
study examined cross-sectional associations between types of fibre and cardiovascular 68 
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disease risk factors. Results showed significant lower risks of hypertension for total and 69 
insoluble fibre intakes, but not for soluble fibre intake (18).  70 
In the present study, we investigated cross-sectional relations to systolic BP (SBP) and 71 
diastolic BP (DBP) of total dietary fibre and its components among the 2,195 participants in 72 
the INTERMAP study in the United States (US) using high-quality dietary data from four 73 
multipass 24-hour dietary recalls, 8 BP measurements, and regression models adjusted 74 
extensively for dietary and lifestyle factors. 75 
Materials and Methods 76 
Population 77 
The INTERnational study on MAcro/micronutrients and blood Pressure (INTERMAP) 78 
included 4,680 men and women ages 40-59 years. Participants were randomly recruited from 79 
community and workforce populations (17 population samples) in Japan, the People's 80 
Republic of China [PRC], the United Kingdom [UK], and the United States [US] (19). 81 
Between 1996 and 1999, participants attended four clinic visits, two on consecutive days and 82 
two on consecutive days approximately three weeks later. Dietary and non-dietary data 83 
collection underwent extensive quality control, including national and international checks to 84 
ensure completeness and accuracy. The study was approved by institutional ethics 85 
committees at all sites. Each participant consented in writing.  86 
Information on types of fibre (insoluble, soluble) is only available for the US samples, we 87 
therefore analysed data on 2,195 participants (1,103 men and 1,092 women) from eight US 88 
population samples. Of 2,281 US participants initially surveyed, individuals were excluded 89 
who did not attend all four visits or had incomplete/missing data, presented unreliable dietary 90 
data, or unavailable 24-hour urine samples (n=65), or had extreme total energy intake from 91 
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any 24-hour recall of <500 or >5,000 kcal/d for women and <500 or >8,000 kcal/d for men 92 
(n=21). 93 
Clinic Visits  94 
Visits were randomly spread over the year. On each of the four visits, BP was measured 95 
twice and twenty-four hour dietary recalls were performed once. Two-timed 24-hour urine 96 
collections were obtained on the second and fourth visits. Height and body weight were 97 
measured twice on the first and third visits. On the first visit, a health history questionnaire 98 
was completed-to collect information on medical history, medication intake, smoking, and 99 
physical activity. On each of the four visits, participants provided information on their 100 
vitamin and supplement intakes.  101 
Dietary Assessment 102 
Four 24-hour dietary recalls were collected from each participant using a standardized multi-103 
pass method reported in detail elsewhere (20). Briefly, trained interviewers collected in depth 104 
data on all foods, beverages, and supplements consumed in the past 24-hours in face-to-face 105 
interviews. In the US, dietary data were transferred to software (the Nutrition Data System 106 
(NDS), Nutrition Coordinating Centre (NCC), version 2.91, University of Minnesota) for on-107 
screen coding during an interview (20). Daily nutrient intakes were obtained by using the 108 
Nutrition Data System for Research (NDS-R), Version 4.01 (20, 21).  For quality control 109 
assessment, dietary recall data were compared to urinary excretion data. Pearson partial 110 
correlation coefficients adjusted for sample and sex between dietary and urinary total protein, 111 
sodium, and potassium were 0.52, 0.46, 0.58 respectively (20).  112 
According to the NCC, insoluble dietary fibre includes cellulose, non-cellulose insoluble 113 
polysaccharides (mostly hemicellulose), lignin, and some resistant starch. Soluble dietary 114 
fibre includes pectins, gums, muscilages and non-cellulose soluble polysaccharides (some 115 
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hemicellulose). We identified all sources of dietary fibre reported by participants: whole 116 
grains (bread and bread products, brown rice and pasta), refined grains (bread and bread 117 
products, pasta, and rice), cereal products (ready to eat cereal, cooked cereal, granola bars), 118 
legumes, vegetables (cooked and raw vegetables), raw fruits, dried fruits, nuts and seeds.  119 
The reliability of fibre intake for individuals was estimated using the following formula: 1/ 120 
[1+ (ratio/2)] x100. The ratio is intra-individual variance divided by the inter-individual 121 
variance, estimated separately by gender, and combined. The averages of the first two and 122 
second two visits were used to account for higher correlation between dietary intakes on 123 
consecutive days. This gives an indication of the effect of random error (day-to-day 124 
variability) on the associations with BP (22).   125 
Measurement of Blood Pressure  126 
SBP and DBP were measured by trained staff using a random-zero sphygmomanometer. 127 
Participants refrained from food, drink, smoking, and physical activity for 30 minutes. They 128 
were seated in a quiet room, bladder emptied, for at least 5 minutes, feet flat on the floor. BP 129 
was measured twice on the right arm at each of four clinic visits, using first and fifth 130 
Korotkoff sounds, totalling eight BP readings.  131 
Other Variables  132 
During two visits, weight and height measurements without shoes or heavy clothing were 133 
collected four times and BMI (kg/m2) was calculated. Urinary sodium, magnesium, calcium, 134 
and potassium were measured from two timed 24-hour urinary samples collected between 135 
consecutive visits. Data on lifestyle factors were assessed using interviewer-guided 136 
questionnaires on smoking, education, hours of physical activity, adherence to a weight 137 
reduction diet, use of antihypertensive and lipid-lowering drugs, individual and family history 138 
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of cardiovascular diseases and diabetes mellitus, and daily alcohol intake during the past 139 
seven days. 140 
Statistical Methods 141 
Statistical analyses were conducted using SAS software version 9.3 (SAS Institute Inc.). 142 
Dietary data were energy-adjusted using the nutrient density method. Dietary intake was 143 
estimated as a mean of the four dietary recalls. The mean value of 8 BP measurements was 144 
used in the analysis. Urinary data were averaged across the two 24-hour urinary collections 145 
(23). Isocaloric models adjusted for total protein, fat, and sugar (%kcal) to enable assessment 146 
of the independent relation of fibre intake (g/1,000 kcal) with BP, including control for total 147 
energy intake (23).   148 
Baseline characteristics of US participants and P for trend across quartiles of total fibre intake 149 
were calculated using a generalized linear model adjusted for age, gender, total energy intake 150 
(kcal/24-hours), total protein (%kcal), total fat (%kcal), and population sample. 151 
Multivariable linear regression analyses were used to examine associations between total, 152 
insoluble, and soluble fibre (per 2 SD: 6.8, 4.6, and 2.2 g/1,000 kcal, respectively) and BP, 153 
including the total US cohort (n=2,195). Additionally, we also applied linear regression 154 
analyses in a subcohort excluding participants with hypertension and use of antihypertensive 155 
drugs, (n=1,477). Three models were used, adjusted extensively for lifestyle and dietary 156 
factors, with and without adjustment for BMI. Potential confounders of the association of 157 
fibre intake with BP were selected from the literature. Model 1 was adjusted for age (years), 158 
gender (male or female), total energy intake (kcal/24-hours), total protein (%kcal), total fat 159 
(%kcal), and population sample (i.e. centre). Model 2 adjusted for variables in Model 1 plus 160 
adherence to a special diet (yes or no), physical activity during leisure time (a lot, moderate, 161 
little, or none), dietary supplement use (yes or no), smoking (never, former, or current), years 162 
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of education (years completed), alcohol intake (g/24-hours), history of cardiovascular disease 163 
or diabetes mellitus (yes or no), family history of cardiovascular disease (yes or no), and 24-164 
hour urinary excretion of sodium (mmol/24-hours). Model 3 was fully adjusted including 165 
variables in model 2 plus 24-hour urinary excretion of sodium (mmol/24-hours).  166 
Additionally, we sequentially investigated the influence of nutrients strongly related to fibre 167 
intake on the association, including 24-hour urinary excretion (mmol/24-hours) of 168 
magnesium calcium and potassium (mmol/24-hours). No missing values were observed.  169 
Analyses were repeated for two subcohorts with characteristics that may bias relations 170 
between fibre intake and BP: (1) a sub cohort of non-hypertensive participants (n=1,421) 171 
additionally excluding participants with elevated SBP  (≥140 mm Hg) or DBP (≥90 mm Hg); 172 
(2) a subcohort free of major chronic diseases (n= 1,262) additionally excluding those 173 
diagnosed with cardiovascular diseases or diabetes. 174 
Interactions by age and sex were examined by inclusion of separate terms in each regression 175 
model; there was no evidence for interaction. Two-tailed probability values (p<0.05) were 176 
considered statistically significant. 177 
Results 178 
Descriptive Statistics 179 
Across quartiles of total fibre intake, participants in the highest quartile of total fibre intake 180 
were older, had more years of education, had greater intakes of total protein, vegetables, raw 181 
fruit, dried fruit, had lower levels of BMI and BP, and lower intakes of alcohol, total sugar, 182 
total fat, and refined grains compared to those in the lowest quartile (Table 1). The 183 
predominant dietary source of total and insoluble fibre was raw fruits (54% and 57%), 184 
followed by refined grains (16% and 14%), vegetables (15% and 12%), and whole grains 185 
cereal products (12% and 13%).  For soluble fibre, dietary sources were raw fruits (48%), 186 
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vegetables (21%), refined grains (19%), and whole grains and cereal products (9%). The 187 
reliability estimate for total fibre intake (g/d) was 82% overall, 80% in men and 83% in 188 
women.  189 
Associations of Total Fibre with BP  190 
After adjustment for lifestyle factors and BMI, total dietary fibre intake higher by 2 SD (6.8 191 
g/1000 kcal) was associated with a SBP lower by 1.69 mm Hg (95% CI: -2.97, -0.41) (Table 192 
2). Additional adjustment for urinary potassium excretion attenuated this association and did 193 
not remain statistically significant (-1.01 mm Hg; 95%CI: -2.35, 0.34).  194 
Associations of Types of Fibre with BP 195 
Insoluble fibre intake higher by 2 SD (4.6 g/1000 kcal) was associated with a 2.07 mm Hg 196 
lower SBP (95% CI: -3.92, -0.23), after adjustment for lifestyle factors, BMI and soluble 197 
fibre (Table 2). Adjustment for urinary potassium attenuated the association and did not 198 
remain statistically significant (-1.81 mm Hg; 95%CI: -3.65, 0.04). Insoluble fibre intake was 199 
also inversely associated with DBP (-1.32 mm Hg; 95%CI: -2.60, -0.04); this association also 200 
attenuated with adjustment for urinary magnesium (-1.23 mm Hg; 95%CI: -2.51,0.06). 201 
Soluble fibre intake was not associated with SBP or DBP.  202 
Associations of Fibre Intakes with BP Excluding Participants with Hypertension and 203 
Use of Antihypertensive Drugs 204 
We repeated the regression analyses in a cohort excluding participants with hypertension and 205 
use of antihypertensive drugs (Table 3). Results showed total dietary fibre intake higher by 2 206 
SD (6.9 g/1000 kcal) was associated with a SBP lower by 1.85 mm Hg (95% CI: -3.13, -207 
0.57). The inverse association between total fibre intake and SBP was independent of urinary 208 
potassium excretion (-1.69 mm Hg; 95%CI: -3.04, -0.34). 209 
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Insoluble fibre intake higher by 2 SD (4.8 g/1000 kcal) was associated with a 2.52 mm Hg 210 
lower SBP (95% CI: -4.42, -0.63), after adjustment for lifestyle factors, BMI and soluble 211 
fibre. The association remained significant after adjustment for urinary potassium (-2.48 mm 212 
Hg; 95%CI: -4.38, -0.58). Soluble fibre intake was not associated with SBP or DBP, as in the 213 
main analyses. 214 
Associations of Fibre Intakes with BP in Subcohorts 215 
We repeated the regression analyses in other subcohorts excluding participants with 216 
characteristics that may bias associations between fibre intake and BP (Table S2): a 217 
subcohort of non-hypertensive participants and a subcohort free of major chronic diseases 218 
(additionally excluding those with cardiovascular diseases and diabetes). Associations 219 
between total, insoluble fibre intake and BP in the two subcohorts were comparable to those 220 
from the main analyses. Although the association between SBP and insoluble fibre was 221 
slightly attenuated in non-hypertensive participants, it remained significant (-1.89 mm Hg 222 
(95% CI: -3.63, -0.15). After further exclusion of participants previously diagnosed with 223 
cardiovascular diseases or diabetes, the association between insoluble fibre and SBP did not 224 
remain statistically significant. Furthermore, analyses were repeated excluding participants 225 
who are taking fibre supplements (n=78). Results were compatible to the main analyses (data 226 
not shown). 227 
Discussion 228 
In this cross-sectional, population-based study of 2,195 Americans participating in the 229 
INTERMAP Study, a higher intake of total dietary fibre was associated with lower BP; this 230 
finding may be attributable by the observed inverse association between insoluble fibre and 231 
SBP but not with soluble fibre.  The associations between total, insoluble dietary fibre and 232 
SBP were attenuated with adjustment for urinary potassium. Results remained significant 233 
with adjustment of BMI and are therefore independent of BMI influence. In the subcohort 234 
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excluding participants with hypertension and use of antihypertensive drugs, the associations 235 
between total, insoluble dietary fibre and BP were independent of nutrients associated with 236 
higher intakes of fibre-rich foods, including potassium. 237 
Previous cross-sectional (4-8, 24, 25), and prospective (4, 5, 9) analyses have reported 238 
inconsistent findings on the association between total dietary fibre intake and BP.  Some 239 
studies analysed cross-sectionally found inverse associations between total fibre intake and 240 
BP (4-6), and some reported no association (7, 8). In prospective cohort studies, inverse 241 
relations between total fibre intake and BP change (9), or risk of developing hypertension (4, 242 
5) were significant in white men and white women only (5, 9) or no longer significant after 243 
adjustment for dietary confounders (5). The inconsistent results may be explained by 244 
methodological issues and differences. First, in most studies results were based on models 245 
that were mainly adjusted for non-dietary confounders (24, 25) or included few dietary 246 
confounders (6, 8, 10). Second, for most studies that examined the association of total fibre 247 
and BP the frequency of BP measurements was typically low (one (7) or two (6, 8) BP 248 
measures) or even based on self-reported data (4, 5). Third, most studies calculated fibre 249 
intakes from single (6, 8), self-administered food frequency questionnaires (4, 5), or 250 
alternatively single 24-hour dietary recalls (6, 7).  Our findings were derived from eight 251 
averaged BP measurements and four high quality 24-hour multipass dietary recalls per person 252 
collected over four visits.  Moreover, we found stronger correlations between dietary and 253 
urinary variables from two timed 24-hour urinary collections in comparison to previously 254 
reported values (26).  Dietary intakes were also energy adjusted using the nutrient density 255 
method and an isocaloric analysis that allows for interpretation of the relation of the nutrient 256 
composition of the diet with the outcome, i.e., BP, while controlling for total energy intake 257 
(23). The availability of urinary collections enabled us to adjust multivariate models for 258 
objective dietary intake measures, which in most other studies is not available.  259 
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The independent association between different types of dietary fibre and BP has been less 260 
thoroughly explored. To our knowledge, this is the first report on possible cross-sectional 261 
associations between total, insoluble, and soluble dietary fibre intakes and BP, measured 262 
eight times, using models adjusted extensively for possible dietary and other lifestyle 263 
confounders. Previously, a cross-sectional analysis including 5,961 middle-aged men and 264 
women of the SUVIMAX study reported that participants in the highest quartiles had a lower 265 
risk of hypertension of 29% for total and 32% for insoluble dietary fibre intakes, with no 266 
association reported for soluble fibre intake. The study showed that 5 g/day higher total fibre 267 
intake was associated with a 12% lower risk of hypertension (18). Though dietary fibre 268 
intakes were estimated by six 24-hour dietary recalls, this study used only one BP 269 
measurement. Another limitation is that analyses were not controlled for several confounding 270 
factors including family history of CVD or high BP. Our results are also compatible with 271 
findings of a recent meta-analysis of 22 cohort studies that showed inverse associations 272 
between insoluble fibre intake and cardiovascular diseases, with no significant associations 273 
for soluble fibre intake, which may be attributed to low soluble fibre intake (27).  274 
BP lowering effects of fibre have previously been attributed to a variety of factors, including 275 
increased nitric oxide release (a vasodilator) (28); improvement in endothelial function by 276 
inhibiting sodium absorption(28), although inconclusive (29); improvement of other 277 
cardiovascular disease risk factors (30), and improved insulin sensitivity and hyperglycaemia 278 
(31, 32).  279 
Participants with diagnosed high BP, cardiovascular disease, or diabetes may have changed 280 
their dietary habits after their diagnosis toward a healthier pattern. Also, those participants 281 
have presumably lower BP levels due to their use of BP lowering medication, which may 282 
distort the relationship between fibre intake and BP level. However, when those participants 283 
were excluded, results were consistently inverse. Based on these findings, it can be posited 284 
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that the inverse associations between total, insoluble fibre and BP observed in our study are 285 
independent of BMI and of nutrients associated with higher intakes of high-fibre foods, 286 
including potassium.  287 
Limitations of our study include its cross-sectional design making causal inferences not 288 
possible, regression dilution bias related to imprecise measures-and the reliability estimate 289 
has been calculated to show the potential of bias (despite repeated measures), systematic bias 290 
from including multiple centres, and possible residual confounding. However, extensive 291 
efforts were made to minimize those limitations (extensive observer training, repeated 292 
measurements of BP, standardized methods in dietary collection and BP measures, open-end 293 
questions, and on-going quality control). In addition, although four 24-hour dietary recalls 294 
were done, the dietary data may not be representative of a participant’s long-term habitual 295 
intake. Also, although the associations between total, insoluble fibre intake and BP were 296 
independent of highly correlated nutrient intakes including potassium, we can’t rule-out that 297 
other nutrients other nutrients and phytochemicals abundant in high-fibre foods may be 298 
responsible for the observed inverse fibre-BP association (33). 299 
In conclusion, in this cross-sectional study of free-living US participants, higher intakes of 300 
total fibre and insoluble fibre were associated with lower BP. Therefore, it may be a 301 
favourable approach to choose fibre-rich foods in the prevention of elevated BP. 302 
Confirmation from large-scale, prospective population studies with high- quality dietary data 303 
and BP measurements and intervention studies is however needed.  304 
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Table 1. Baseline characteristics of US INTERMAP participants by quartiles of total fibre intake, n=2,1951,2 
Variable Q1 Q2 Q3 Q4 P for trend 
n 548 549 549 549  
Men (%) 50% 50% 50% 50%  
Total fibre (g/1000 kcal) 5 (0.1) 8 (0.1) 9 (0.1) 12 (0.1) <0.0001 
Insoluble fibre  (g/1000 kcal) 3 (0.1) 5 (0.1) 6 (0.1) 8 (0.1) <0.0001 
Soluble fibre  (g/1000 kcal) 2 (0.03) 3 (0.03) 3 (0.03) 4 (0.03) <0.0001 
Age (y) 48 (0.2) 49 (0.2) 49 (0.2) 50 (0.2) <0.0001 
Education (y) 14 (0.1) 15 (0.1) 15 (0.1) 15 (0.1) <0.0001 
Current smokers (%) 26% 
 
 19%  13%  9%  <0.0001 
Alcohol intake (g/d) 7 (1) 8 (1) 8 (1) 5 (1) <0.0001 
Engagement in moderate and heavy 
physical activity (h/d) 
4 (0.1) 3 (0.1) 3 (0.1) 3 (0.1) 0.12 
Taking dietary supplements (%) 40%  52%  56%  60%  <0.0001 
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BMI (kg/m2) 30.1 (0.3) 29.0 (0.3) 28.5 (0.2) 28.1 (0.3) <0.0001 
Systolic BP (mm Hg) 120.6 (0.6) 119.2 (0.6) 118.4 (0.6) 116.3 (0.6) <0.0001 
Diastolic BP (mm Hg) 74.4 (0.4) 73.7 (0.4) 73.3 (0.4) 72.2 (0.4) 0.003 
History of cardiovascular disease or 
diabetes mellitus (%) 
14%  18%  15%  15%  0.53 
Use of antihypertensive and/or 
cardiovascular disease treatment (%) 
27%  22%  24%  22%  0.17 
Family history of hypertension (%) 70%  66%  70%  66%  0.32 
Adhering to energy restricted diet (%) 5%  5%  7%  11%  <0.0001 
Total energy intake (kcal/24-hour) 2,360 (24) 2,278 (24) 2233 (24) 2098 (25) <0.0001 
Sugar (%kcal) 29 (0.3) 27 (0.3) 26 (0.3) 26 (0.3) <0.0001 
Total protein (%kcal) 15 (0.1) 15 (0.1) 16 (0.1) 16 (0.1) <0.0001 
Total fat (%kcal) 35 (0.3) 34 (0.3) 33 (0.3) 29 (0.3) <0.0001 
Urinary samples (mmol/24-hour)          
  22 
Urinary sodium  155.3 (2.3) 163 (2.2) 164.8 (2.2) 167.3 (2.4) 0.003 
Urinary magnesium  3.7 (0.1) 4 (0.1) 4.4 (0.1) 4.8 (0.1) <0.0001 
Urinary calcium 3.9 (0.1) 4 (0.1) 4.4 (0.1) 4.4 (0.1) 0.0003 
Urinary potassium  49.2 (0.8) 55 (0.8) 60.8 (0.8) 66.0 (0.8) <0.0001 
Dietary sources (g/1000 kcal)          
Whole grain and fibre rich cereal 7 (4) 5 (4) 8 (4) 14 (4) 0.08 
Refined grains 32 (1) 29 (1) 30 (1) 26 (1) 0.01 
Legumes 0.2 (1) 0.2 (1) 0.2 (1) 2.3 (1) 0.01 
Nuts and seeds 0.1 (0.1) 0.1 (0.1) 0.3 (0.1) 0.4 (0.1) 0.67 
Vegetables 43 (3) 55 (4) 67 (4) 80 (4) <0.0001 
Raw fruit 25 (2) 38 (2) 44 (2) 55 (2) <0.0001 
Dried fruit 2 (1) 2 (1) 3 (1) 4 (1) 0.004 
1 Mean (SE) or (%) 
2 The generalized linear model was adjusted for age, gender, total energy (kcal/24-hour), total protein (%kcal), total fat (%kcal), total sugar (%kcal),    
and population sample. 
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Table 2. Estimated mean difference in BP associated with 2 SD higher intakes of total fibre, insoluble fibre, and soluble fibre in US INTERMAP 
participants (n=2,195) 1 
  SBP   DBP   
  Not adjusted for BMI Adjusted for BMI   Not adjusted for BMI Adjusted for BMI   
Model Difference 95% CI p Difference 95% CI p Difference 95% CI p Differen
ce 
95% CI p 
 mm Hg mm Hg  mm Hg mm Hg  mm Hg mm Hg  mm Hg mm Hg  
Total fibre  
  
                      
Model 1 -3.45 (-4.74, -2.16) <0.0001 -2.35 (-3.58, -1.11) 0.0002 -1.80 (-2.68, -0.92) <0.0001 -1.18 (-2.04, -0.33) 0.01 
Model 2 -2.88 (-4.20, -1.55) <0.0001 -1.69 (-2.96, -0.41) 0.01 -1.53 (-2.43, -0.62) 0.001 -0.85 (-1.73, 0.04) 0.06 
Model 3 -2.91 (-4.23, -1.59) <0.0001 -1.69 (-2.97, -0.41) 0.01 -1.54 (-2.45, -0.64) 0.001 -0.84 (-1.73, 0.05) 0.06 
Model 4 -2.95 (-4.31, -1.59) <0.0001 -1.63 (-2.94, -0.33) 0.01 -1.48 (-2.41, -0.56) 0.002 -0.73 (-1.63, 0.18) 0.12 
Model 5 -2.90 (-4.22, -1.57) <0.0001 -1.73 (-3.01, -0.45) 0.01 -1.54 (-2.45, -0.64) 0.001 -0.87 (-1.76, 0.02) 0.05 
Model 6 -2.66 (-4.05, -1.27) 0.0002 -1.01 (-2.35, 0.34) 0.14 -1.37 (-2.32, -0.42) 0.01 -0.42 (-1.35, 0.51) 0.38 
Insoluble fibre 2 
  
                      
Model 1 -3.56 (-5.50, -1.62) 0.0003 -2.45 (-4.30, -0.60) 0.01 -2.23 (-3.55, -0.91) 0.001 -1.61 (-2.89, -0.33) 0.01 
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Model 2 -3.19 (-5.11, -1.27) 0.001 -2.07 (-3.91, -0.23) 0.03 -1.96 (-3.28, -0.65) 0.004 -1.32 (-2.60, -0.04) 0.04 
Model 3 -3.15 (-5.07, -1.23) 0.001 -2.07 (-3.92, -0.23) 0.03 -1.94 (-3.26, -0.63) 0.004 -1.32 (-2.60, -0.04) 0.04 
Model 4 -3.23 (-5.17, -1.29) 0.001 -2.01 (-3.87, -0.16) 0.03 -1.92 (-3.25, -0.60) 0.004 -1.23 (-2.51, 0.06) 0.06 
Model 5 -3.15 (-5.07, -1.23) 0.001 -2.05 (-3.89, -0.20) 0.03 -1.95 (-3.26, -0.63) 0.004 -1.32 (-2.59, -0.04) 0.04 
Model 6 -3.10 (-5.03, -1.17) 0.002 -1.81 (-3.65, 0.04) 0.06 -1.90 (-3.22, -0.58) 0.01 -1.16 (-2.44, 0.12) 0.08 
Soluble fibre 3 
  
                      
Model 1 0.10 (-1.88, 2.09) 0.92 -0.02 (-1.91, 1.86) 0.98 0.37 (-0.98, 1.72) 0.59 0.30 (-1.01, 1.72) 0.65 
Model 2 0.42 (-1.54, 2.39) 0.67 0.42 (-1.46, 2.30) 0.66 0.40 (-0.94, 1.75) 0.56 0.40 (-0.90, 1.70) 0.55 
Model 3 0.32 (-1.64, 2.28) 0.75 0.42 (-1.46, 2.29) 0.66 0.35 (-0.99, 1.69) 0.61 0.41 (-0.90, 1.71) 0.54 
Model 4 0.40 (-1.57, 2.37) 0.69 0.41 (-1.47, 2.29) 0.67 0.41 (-0.94, 1.75) 0.55 0.42 (-0.89, 1.72) 0.53 
Model 5 0.36 (-1.60, 2.32) 0.72 0.35 (-1.52, 2.23) 0.71 0.37 (-0.97, 1.71) 0.59 0.37 (-0.94, 1.67) 0.58 
Model 6 0.61 (-1.38, 2.59) 0.55 0.88 (-1.01, 2.78) 0.36 0.53 (-0.83, 1.88) 0.45 0.68 (-0.63, 2.00) 0.31 
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1 2SD fibres (g/1000 kcal) total fibre (6.8); insoluble fibre (4.6); soluble fibre (2.2). Model 1 was adjusted for age, gender, total energy (kcal/24-hour), total protein 
(%kcal), total fat (%kcal), total sugar (%kcal), and population sample. Model 2 was adjusted as model 1 variables plus adherence to energy restricted diet, smoking, 
alcohol intake (g/24-hour), hours engaged in moderate and heavy physical activity, dietary supplement use, educational level, cardiovascular disease or diabetes 
diagnosis, and family history of high BP. Model 3 was adjusted as model 2 plus urinary sodium (mmol/24-hour).  Model 4 was adjusted as model 3 plus urinary 
magnesium (mmol/24-hour). Model 5 was adjusted as model 3 plus urinary calcium (mmol/24-hour). Model 6 was adjusted as model 3 plus urinary potassium 
(mmol/24-hour). 2 Additionally adjusted for soluble fibre (g/1000 kcal). 3 Additionally adjusted for insoluble fibre (g/1000 kcal). 
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Table 3. Estimated mean difference in BP associated with 2 SD higher intakes of total fibre, insoluble fibre, and soluble fibre in US INTERMAP 
participants, excluding those with hypertension and users of antihypertensive drug (n=1,477) 1 
  SBP   DBP   
  Not adjusted for BMI Adjusted for BMI   Not adjusted for BMI Adjusted for BMI   
Model Difference 95% CI p Difference 95% CI p Difference 95% CI p Difference 95% CI p 
 mm Hg mm Hg  mm Hg mm Hg  mm Hg mm Hg  mm Hg mm Hg  
Total fibre  
  
                      
Model 1 -3.50 (-4.80, -2.20) <0.0001 -3.45 (-4.74, -2.16) <0.0001 -2.01 (-2.95, -1.06) <0.0001 -1.47 (-2.37, -0.56) 0.002 
Model 2 -2.76 (-4.11, -1.40) <0.0001 -1.82 (-3.10, -0.54) 0.01 -1.77 (-2.75, -0.78) 0.0004 -1.19 (-2.13, -0.24) 0.01 
Model 3 -2.77 (-4.12, -1.43) <0.0001 -1.85 (-3.13, -0.57) 0.005 -1.78 (-2.75, -0.80) 0.0004 -1.19 (-2.14, -0.25) 0.01 
Model 4 -3.06 (-4.44, -1.68) <0.0001 -2.05 (-3.36, -0.74) 0.002 -1.87 (-2.87, -0.87) 0.0003 -1.24 (-2.20, -0.27) 0.01 
Model 5 -2.70 (-4.05, -1.35) <0.0001 -1.79 (-3.07, -0.52) 0.01 -1.73 (-2.71, -0.76) 0.001 -1.17 (-2.11, -0.23) 0.02 
Model 6 -3.02 (-4.43, -1.60) <0.0001 -1.69 (-3.04, -0.34) 0.014 -1.96 (-2.99, -0.93) 0.0002 -1.15 (-2.14, -0.15) 0.02 
Insoluble fibre 2 
  
                      
Model 1 -3.80 (-5.80, -1.79) 0.0002 -3.08 (-4.98, -1.19) 0.001 -2.90 (-4.36, -1.45) <0.0001 -2.46 (-3.85, -1.06) 0.001 
Model 2 -3.29 (-5.30, -1.28) 0.001 -2.54 (-4.44, -0.65) 0.01 -2.60 (-4.05, -1.14) 0.001 -2.13 (-3.53, -0.74) 0.003 
Model 3 -3.15 (-5.15, -1.15) 0.002 -2.52 (-4.42, -0.63) 0.01 -2.52 (-3.97, -1.07) 0.001 -2.13 (-3.52, -0.73) 0.003 
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Model 4 -3.51 (-5.53, -1.50) 0.001 -2.71 (-4.62, -0.81) 0.01 -2.67 (-4.14, -1.21) 0.0004 -2.18 (-3.58, -0.77) 0.002 
Model 5 -3.25 (-5.25, -1.25) 0.002 -2.52 (-4.41, -0.63) 0.01 -2.57 (-4.03, -1.12) 0.001 -2.12 (-3.52, -0.73) 0.003 
Model 6 -3.37 (-5.39, -1.36) 0.001 -2.48 (-4.38, -0.58) 0.01 -2.66 (-4.12, -1.20) 0.0004 -2.11 (-3.51, -0.71) 0.003 
Soluble fibre 3 
  
                      
Model 1 0.33 (-1.66, 2.32) 0.74 0.36 (-1.51, 2.23) 0.70 0.88 (-0.56, 2.32) 0.23 0.90 (-0.48, 2.28) 0.20 
Model 2 0.68 (-1.30, 2.66) 0.50 0.79 (-1.07, 2.66) 0.41 0.82 (-0.62, 2.26) 0.26 0.89 (-0.49, 2.26) 0.21 
Model 3 0.48 (-1.50, 2.45) 0.64 0.74 (-1.13, 2.60) 0.44 0.71 (-0.72, 2.14) 0.33 0.87 (-0.51, 2.25) 0.22 
Model 4 0.63 (-1.35, 2.61) 0.54 0.75 (-1.11, 2.61) 0.43 0.80 (-0.64, 2.24) 0.27 0.88 (-0.50, 2.25) 0.21 
Model 5 0.72 (-1.25, 2.69) 0.47 0.82 (-1.04, 2.68) 0.39 0.84 (-0.59, 2.27) 0.25 0.90 (-0.47, 2.28) 0.20 
Model 6 0.55 (-1.45, 2.55) 0.59 0.89 (-0.99, 2.77) 0.35 0.71 (-0.74, 2.16) 0.34 0.92 (-0.47, 2.31) 0.19 
1 2SD fibres (g/1000 kcal) total fibre (6.9); insoluble fibre (4.8); soluble fibre (2.2). Model 1 was adjusted for age, gender, total energy (kcal/24-hour), total protein 
(%kcal), total fat (%kcal), total sugar (%kcal), and population sample. Model 2 was adjusted as model 1 variables plus adherence to energy restricted diet, 
smoking, alcohol intake (g/24-hour), hours engaged in moderate and heavy physical activity, dietary supplement use, educational level, cardiovascular disease or 
diabetes diagnosis, and family history of high BP. Model 3 was adjusted as model 2 plus urinary sodium (mmol/24-hour).  Model 4 was adjusted as model 2 plus 
urinary magnesium (mmol/24-hour). Model 5 was adjusted as model 2 plus urinary calcium (mmol/24-hour). Model 6 was adjusted as model 2 plus urinary 
potassium (mmol/24-hour). 2 Additionally adjusted for soluble fibre (g/1000 kcal). 3 Additionally adjusted for insoluble fibre (g/1000 kcal). 
   
